|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - RHYTHM PHARMACEUTICALS Inc (RYTM)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-12-03 Sale |
2018-12-06 4:03 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
563 | $30 | $16,890 | 571,476 (Direct) |
View |
| 2018-11-02 Sale |
2018-11-06 5:21 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
16,500 | $30.08 | $496,320 | 572,039 (Direct) |
View |
| 2018-11-02 Sale |
2018-11-06 5:20 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
38,000 | $30.09 | $1,143,420 | 80,539 (Direct) |
View |
| 2018-09-25 Sale |
2018-09-27 4:02 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
31,800 | $29.8 | $947,540 | 84,139 (Direct) |
View |
| 2018-05-22 Sale |
2018-05-24 4:13 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC 10% Owner |
19,580 | $30.43 | $595,768 | 2,751,679 (Indirect) |
View |
| 2018-05-18 Sale |
2018-05-21 6:15 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC 10% Owner |
131,636 | $30.88 | $4,065,440 | 2,832,159 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-11 2:25 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | MPM BIOVENTURES V L.P. EVNIN LUKE GADICKE ANSBERT MPM ASSET MANAGEMENT INVESTORS BV5 LLC MPM BIOVENTURES V GP LLC MPM BIOVENTURES V LLC 10% Owner |
100,000 | $17 | $1,700,000 | 2,696,392 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-11 2:24 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director, 10% Owner |
100,000 | $17 | $1,700,000 | 3,015,915 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:36 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Viswanathan Ravi 10% Owner |
550,000 | $17 | $9,350,000 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:35 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | SANDELL SCOTT D 10% Owner |
550,000 | $17 | $9,350,000 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:35 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | MOTT DAVID M 10% Owner |
550,000 | $17 | $9,350,000 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:34 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | KERINS PATRICK J 10% Owner |
550,000 | $17 | $9,350,000 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:34 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | BASKETT FOREST 10% Owner |
550,000 | $17 | $9,350,000 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:33 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | BARRIS PETER J 10% Owner |
550,000 | $17 | $9,350,000 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:33 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | BARRETT M JAMES 10% Owner |
550,000 | $17 | $9,350,000 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:32 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner |
550,000 | $17 | $9,350,000 | 4,909,956 (Direct) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:24 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Meeker David P Director |
25,000 | $17 | $425,000 | 101,335 (Direct) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:22 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | PFIZER INC 10% Owner |
40,000 | $17 | $680,000 | 1,427,639 (Direct) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:22 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | Ipsen S.A. 10% Owner |
20,000 | $17 | $340,000 | 833,099 (Indirect) |
View |
| 2017-10-10 Purchase |
2017-10-10 4:21 pm |
RHYTHM PHARMACEUTICALS Inc | RYTM | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC ISALY SAMUEL D 10% Owner |
355,000 | $17 | $6,035,000 | 2,901,295 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
8,200 | $4.59 | 80,539 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
10,000 | $6.14 | 80,539 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
10,000 | $7.52 | 80,539 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A 2025-11-16 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
8,200 | $4.59 | 80,539 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A 2027-04-04 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
10,000 | $6.14 | 80,539 (Direct) |
View |
| 2018-11-02 Exercise |
2018-11-06 5:20 pm |
N/A 2025-12-30 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
10,000 | $7.52 | 80,539 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-17 5:30 pm |
N/A 2028-10-14 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Stewart Murray Chief Medical Officer |
100,000 | $26.54 | 100,000 (Direct) |
View |
| 2018-09-25 Gift |
2018-09-27 4:02 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
2,000 | $0 | 84,139 (Direct) |
View |
| 2018-09-25 Exercise |
2018-09-27 4:02 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
21,800 | $4.59 | 84,139 (Direct) |
View |
| 2018-09-25 Exercise |
2018-09-27 4:02 pm |
N/A 2025-11-16 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
21,800 | $4.59 | 84,139 (Direct) |
View |
| 2018-09-05 Exercise |
2018-09-06 4:02 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO |
3,000 | $6.88 | 198,744 (Direct) |
View |
| 2018-09-05 Exercise |
2018-09-06 4:02 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO |
3,000 | $6.88 | 198,744 (Direct) |
View |
| 2018-08-30 Other |
2018-09-04 4:06 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J 10% Owner |
1,000,000 | $0 | 2,981,437 (Direct) |
View |
| 2018-08-10 Exercise |
2018-08-14 4:01 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer |
14,534 | $6.88 | 187,210 (Direct) |
View |
| 2018-08-10 Exercise |
2018-08-14 4:01 pm |
N/A 2027-08-08 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer |
14,534 | $6.88 | 187,210 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 5:04 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Mathers Edward T Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:09 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Kelner Simon Chief Human Resources Officer |
60,000 | $34.89 | 60,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:08 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | JEAN CHRISTOPHE Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:06 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Exter Neil Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:06 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Meeker David P Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:04 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | MCGIRR DAVID W J Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-06-06 Option Award |
2018-06-08 4:03 pm |
N/A 2028-06-05 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director |
10,000 | $34.89 | 10,000 (Direct) |
View |
| 2018-05-09 Exercise |
2018-05-10 4:08 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
3,000 | $4.59 | 588,539 (Direct) |
View |
| 2018-05-09 Exercise |
2018-05-10 4:08 pm |
N/A 2025-11-16 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
3,000 | $4.59 | 588,539 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:03 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Smith Hunter C CFO |
61,000 | $25.79 | 61,000 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:03 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
175,000 | $25.79 | 175,000 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:03 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Fiedorek Fred T. Chief Medical Officer |
25,000 | $25.79 | 25,000 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:03 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Fiedorek Fred T. Chief Medical Officer |
25,000 | $25.79 | 25,000 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:02 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Desikan Nithya Chief Commercial Officer |
61,000 | $25.79 | 61,000 (Direct) |
View |
| 2018-02-14 Option Award |
2018-02-16 4:02 pm |
N/A 2028-02-13 |
RHYTHM PHARMACEUTICALS Inc | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer |
55,000 | $25.79 | 55,000 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-12 5:16 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Exter Neil Director |
0 | $0 | 0 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-12 5:16 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Exter Neil Director |
0 | $0 | 0 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-12 5:16 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Exter Neil Director |
0 | $0 | 0 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-11 4:00 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner |
3,963,810 | $0 | 3,981,437 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-11 4:00 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner |
9,479,502 | $0 | 3,981,437 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-11 4:00 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner |
26,868,642 | $0 | 3,981,437 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-11 2:25 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | MPM BIOVENTURES V L.P. EVNIN LUKE GADICKE ANSBERT MPM ASSET MANAGEMENT INVESTORS BV5 LLC MPM BIOVENTURES V GP LLC MPM BIOVENTURES V LLC 10% Owner |
2,567,014 | $0 | 2,696,392 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-11 2:25 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | MPM BIOVENTURES V L.P. EVNIN LUKE GADICKE ANSBERT MPM ASSET MANAGEMENT INVESTORS BV5 LLC MPM BIOVENTURES V GP LLC MPM BIOVENTURES V LLC 10% Owner |
7,651,831 | $0 | 2,696,392 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-11 2:25 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | MPM BIOVENTURES V L.P. EVNIN LUKE GADICKE ANSBERT MPM ASSET MANAGEMENT INVESTORS BV5 LLC MPM BIOVENTURES V GP LLC MPM BIOVENTURES V LLC 10% Owner |
15,887,703 | $0 | 2,696,392 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-11 2:24 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director, 10% Owner |
2,567,014 | $0 | 3,015,915 (Indirect) |
View |
| 2017-10-10 Option Award |
2017-10-11 2:24 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director, 10% Owner |
3,015,915 | $1 | 3,015,915 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-11 2:24 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director, 10% Owner |
7,651,831 | $0 | 3,015,915 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-11 2:24 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Foley Todd Director, 10% Owner |
15,887,703 | $0 | 3,015,915 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:36 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Viswanathan Ravi 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:36 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Viswanathan Ravi 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:36 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Viswanathan Ravi 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:36 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Viswanathan Ravi 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:35 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | SANDELL SCOTT D 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:35 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | SANDELL SCOTT D 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:35 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | SANDELL SCOTT D 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:35 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | SANDELL SCOTT D 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:35 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | MOTT DAVID M 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:35 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | MOTT DAVID M 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:35 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | MOTT DAVID M 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:35 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | MOTT DAVID M 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:34 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | KERINS PATRICK J 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:34 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | KERINS PATRICK J 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:34 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | KERINS PATRICK J 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:34 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | KERINS PATRICK J 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:34 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BASKETT FOREST 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:34 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BASKETT FOREST 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:34 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BASKETT FOREST 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:34 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BASKETT FOREST 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:33 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BARRIS PETER J 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:33 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BARRIS PETER J 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:33 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BARRIS PETER J 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:33 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BARRIS PETER J 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:33 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BARRETT M JAMES 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:33 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BARRETT M JAMES 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:33 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BARRETT M JAMES 10% Owner |
1,402,870 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:33 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | BARRETT M JAMES 10% Owner |
2,927,708 | $0 | 4,909,956 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:32 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner |
1,402,870 | $0 | 4,909,956 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:32 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner |
2,927,708 | $0 | 4,909,956 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:32 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner |
1,402,870 | $0 | 4,909,956 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:32 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner |
2,927,708 | $0 | 4,909,956 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:24 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Meeker David P Director |
54,525 | $0 | 101,335 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:24 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Meeker David P Director |
54,525 | $0 | 101,335 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:23 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
27,262 | $0 | 585,539 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:23 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Gottesdiener Keith Michael CEO |
27,262 | $0 | 585,539 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:22 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | PFIZER INC 10% Owner |
447,514 | $0 | 1,427,639 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:22 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | PFIZER INC 10% Owner |
940,125 | $0 | 1,427,639 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:22 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | PFIZER INC 10% Owner |
447,514 | $0 | 1,427,639 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:22 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | PFIZER INC 10% Owner |
940,125 | $0 | 1,427,639 (Direct) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:22 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Ipsen S.A. 10% Owner |
45,831 | $0 | 833,099 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:22 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Ipsen S.A. 10% Owner |
167,938 | $0 | 833,099 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:22 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Ipsen S.A. 10% Owner |
45,831 | $0 | 833,099 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:22 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | Ipsen S.A. 10% Owner |
167,938 | $0 | 833,099 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:21 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC ISALY SAMUEL D 10% Owner |
2,546,295 | $0 | 2,901,295 (Indirect) |
View |
| 2017-10-10 Conversion |
2017-10-10 4:21 pm |
N/A N/A |
RHYTHM PHARMACEUTICALS Inc | RYTM | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC ISALY SAMUEL D 10% Owner |
2,546,295 | $0 | 2,901,295 (Indirect) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Mon, 17 Dec 2018 04:16:24 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |